Gary Nachman
Stock Analyst at Raymond James
(0.48)
# 1817
Out of 5,271 analysts
146
Total ratings
53.03%
Success rate
5.01%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AbbVie | Reiterates: Outperform | 218 220 | 212.25 | 3.65% | 14 | Feb 3, 2025 | |
Schrodinger | Maintains: Outperform | 25 28 | 20.07 | 39.51% | 5 | Nov 13, 2024 | |
Alnylam Pharmaceutic... | Maintains: Outperform | 275 298 | 240.19 | 24.07% | 7 | Nov 1, 2024 | |
LENZ Therapeutics | Initiates Coverage On: Outperform | 37 | 21.82 | 69.57% | 1 | Sep 27, 2024 | |
Achieve Life Science... | Initiates Coverage On: Strong Buy | 20 | 2.87 | 596.86% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 41 37 | 23.22 | 59.35% | 13 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | 15.6 | 21.79% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 3 | 0.49 | 512.24% | 1 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Strong Buy | 30 | 35.55 | -15.61% | 5 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 2.6 | 169.23% | 1 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 1 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 11 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 4 | 8.78 | -54.44% | 5 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 30 | 5.29 | 467.11% | 4 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 67 | 32.27 | 107.62% | 2 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 32 | 2.23 | 1334.98% | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 16 14 | 9.41 | 48.78% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 10 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 75 | 5.3 | 1315.09% | 4 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 35 | n/a | n/a | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 43 40 | 7.18 | 457.1% | 8 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 11 10 | 15.39 | -35.02% | 1 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 30 | 21.36 | 40.45% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 2 | n/a | n/a | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 810 750 | 2.95 | 25323.73% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 15 8 | 7.08 | 12.99% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 4 2 | n/a | n/a | 5 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 20 12 | n/a | n/a | 6 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 20 21 | 27.49 | -23.61% | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | n/a | n/a | 4 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 4 3 | n/a | n/a | 4 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 76 32 | n/a | n/a | 3 | Aug 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 14 | 3.23 | 333.44% | 2 | Jun 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 18 20 | n/a | n/a | 2 | Apr 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 16 17 | n/a | n/a | 3 | Nov 13, 2017 |